Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial. (Q46817262)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18182617%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18182617%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18182617%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Angelo Di Leo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18182617%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

17

Aron Goldhirsch

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18182617%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

John Crown

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18182617%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Marc Buyse

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18182617%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Ana Balil

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18182617%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Michael Andersson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18182617%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Bo Nordenskjöld

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18182617%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Istvan Lang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18182617%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Raimund Jakesz

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18182617%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Daniel Vorobiof

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18182617%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Jorge Gutiérrez

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18182617%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Guy van Hazel

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18182617%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Stella Dolci

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18182617%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Sophie Jamin

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18182617%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Belguendouz Bendahmane

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18182617%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Richard D Gelber

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18182617%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Monica Castiglione-Gertsch

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18182617%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Martine Piccart-Gebhart

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18182617%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

BIG 02-98 Collaborative Group

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18182617%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

English

0 references

publication date

8 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18182617%20AND%20SRC:MED&resulttype=core&format=json

Journal of the National Cancer Institute

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18182617%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18182617%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

121-133

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18182617%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18182617%20AND%20SRC:MED&resulttype=core&format=json

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM287

A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM287

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM287

Adjuvant docetaxel for node-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM287

Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM287

Predicting the course of Gompertzian growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM287

Doxorubicin with cyclophosphamide followed by docetaxel every 21 days compared with doxorubicin and docetaxel every 14 days as preoperative treatment in operable breast cancer: the GEPARDUO study of the German Breast Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM287

Multicenter randomized trial comparing sequential with concomitant administration of doxorubicin and docetaxel as first-line treatment of metastatic breast cancer: a Spanish Breast Cancer Research Group (GEICAM-9903) phase III study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM287

Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an anglo-celtic cooperative oncology group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM287

Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM287

Patients' preferences for adjuvant chemotherapy in early breast cancer: a review of what makes it worthwhile

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM287

Phase III Trial Comparing Three Doses of Docetaxel for Second-Line Treatment of Advanced Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM287

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM287

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJM287

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18182617%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference